Skip to main content
Carol Tamminga, MD, Psychiatry, Dallas, TX, UT Southwestern Zale Lipshy Hospital

CarolAnnTammingaMD

Psychiatry • Dallas, TX

Neuropsychiatry

Professor & Chairman, Psychiatry, University of Texas Southwestern Medical Center

Join to view full profile

Dr. Tamminga is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tamminga's full profile

Already have an account?

Education & Training

  • University of Chicago
    University of ChicagoResidency, Psychiatry, 1972 - 1975
  • Grand Rapids Medical Education and Research Center/ Michigan State University (East Campus)
    Grand Rapids Medical Education and Research Center/ Michigan State University (East Campus)Internship, Transitional Year, 1971 - 1972
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1971
  • Calvin College Health Center
    Calvin College Health CenterB.S., Biochemistry, 1963 - 1966

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2003 - 2027
  • TX State Medical License
    TX State Medical License 2003 - 2026
  • MD State Medical License
    MD State Medical License 1981 - 2015
  • IL State Medical License
    IL State Medical License 1972 - 1987

Awards, Honors, & Recognition

  • Gold Award society of Biological Psychiatry, 2019
  • Program Chair Award Society for Neuroscience, 2013
  • Founders Award International Congress on Schizophrenia Research, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Using Brain-Based Phenotyping to Improve Discovery in Psychiatry  
    Carol A Tamminga, Elena I Ivleva, JAMA
  • New Approaches in Psychiatric Drug Development  
    Wayne C Drevets, Carol A Tamminga, European Neuropsychopharmacology
  • Animal models of schizophrenia emphasizing constructvalidity  
    Yanagi M, Southcott S, Lister J, Tamminga CA, Prog Mol Biol Transl Sci, 1/1/2012
  • Join now to see all

Authored Content

  • New Approaches in Psychiatric Drug DevelopmentJuly 2018
  • S188. Emotional Processing in Bipolar Disorder with and Without Psychosis: Findings from the Psychosis and Affective Research Domains and Intermediate Phenotypes ConsortiumApril 2018
  • S188. Emotional Processing in Bipolar Disorder with and Without Psychosis: Findings from the Psychosis and Affective Research Domains and Intermediate Phenotypes ConsortiumApril 2018
  • WelcomeMarch 2018
  • WelcomeMarch 2018
  • Join now to see all

Press Mentions

  • DFW’s State Hospital Will Be by and for the People
    DFW’s State Hospital Will Be by and for the PeopleJanuary 11th, 2022
  • NS/ Brain Study on How to Slow down Climate Change
    NS/ Brain Study on How to Slow down Climate ChangeDecember 22nd, 2021
  • First Human Evidence of How Memories Form: Study
    First Human Evidence of How Memories Form: StudyDecember 14th, 2021
  • Join now to see all

Grant Support

  • Antipsychotic Influence On Altered MTL Neuronal Activity In SchizophreniaNational Institute Of Mental Health2009–2012
  • Project 5-Creb And The Other Targets In Projects 1-4 In Reward Regions In DepressNational Institute Of Mental Health2010–2011
  • Basic Science Training Program In The Neurobiology Of Mental IllnessNational Institute Of Mental Health2007–2011
  • Bipolar &Schizophrenia Consortium For Parsing Intermediate PhenotypesNational Institute Of Mental Health2007–2010
  • Project 5-Creb And The Other Targets In Projects 1-4 In Reward Regions In DepressNational Institute Of Mental Health2008–2009
  • Treating Cognition In SchizophreniaNational Institute Of Mental Health2007–2009
  • Project 5-Creb And The Other Targets In Projects 1-4 In Reward Regions In DepressNational Institute Of Mental Health2007
  • Comparitive Antipsychotic Drug Actions On Brain NeurochemistryNational Institute Of Mental Health2007
  • Psychiatric Research Education Program(Prep)National Institute Of Mental Health2006–2007
  • Comparitive Antipsychotic Drug Actions On Brain NeurocheNational Institute Of Mental Health2004–2006
  • Examination Of The Limbic Cortex In SchizophreniaNational Institute Of Mental Health2003–2006
  • Antipsychotic Drug Actions On Brain NeurochemistryNational Institute Of Mental Health2003
  • Examination Of The Limbic Cortex In SchizophreniaNational Institute Of Mental Health2002
  • Partial Dopamineagonist Treatment Of SchizophreniaNational Institute Of Mental Health2001–2002
  • Clinical Biology CoreNational Institute Of Mental Health1998–2002
  • Partial Dopamine Agonist Treatment Of SchizophreniaNational Institute Of Mental Health2000
  • GABA Agonist Therapy In Tardive DyskinesiaNational Institute Of Mental Health1985–1999
  • Clinical Biochemistry Laboratory CoreNational Institute Of Mental Health1996–1997
  • Partial Dopamine Agonists--Treatment Of SchizophreniaNational Institute Of Mental Health1995–1997
  • Partial Dopamine Agonists In Treatment Of SchizophreniaNational Institute Of Mental Health1992–1994
  • GABA Agonist Therapy In Tardive DyskinesiaNational Institute Of Mental Health1987–1994
  • Regional Brain Glucose UtilizationNational Institute Of Mental Health1987–1989
  • Haloperidol Kinetics In Persistent PsychosisNational Institute Of Mental Health1986–1988

Hospital Affiliations

Dr. Carol Tamminga, Dr. Carol Tamminga, MD, Dr. C Tamminga, Dr. Carol Ann Tamminga